Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,516.27 98.74 0.68%
TOPIX 1,173.37 6.78 0.58%
HANG SENG 22,760.24 64.23 0.28%

Abaxis, Inc. to Present at the Stephens Fall Investment Conference



      Abaxis, Inc. to Present at the Stephens Fall Investment Conference

PR Newswire

UNION CITY, Calif., Nov. 6, 2013

UNION CITY, Calif., Nov. 6, 2013 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS:
ABAX), a medical products company manufacturing point-of-care blood
instrumentation and consumables to the medical, research and veterinary
markets, announced today that Don Wood, Chief Operations Officer, will present
at the Stephens 2013 Fall Investment Conference on Wednesday, November 13,
2013 at 2:00 p.m. ET. The conference will be held at The New York Palace Hotel
in New York City.

About Abaxis
Abaxis develops, manufactures, markets and sells portable blood analysis
systems for use in any veterinary or human patient-care setting to provide
clinicians with rapid blood constituent measurements.  The system consists of
a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of
single-use plastic discs, called reagent discs that contain all the chemicals
required to perform a panel of up to 13 tests on veterinary patients and 14
tests on human patients.  The system can be operated with minimal training and
performs multiple routine tests on whole blood, serum or plasma samples.  The
system provides test results in less than 12 minutes with the precision and
accuracy equivalent to a clinical laboratory analyzer.  The veterinary
business also provides to the animal health and research market a line of
hematology instruments for point-of-care complete blood counts (CBC), a
specialty instrument to screen for and detect clotting disorders and to
measure equine fibrinogen levels, a handheld instrument for the rapid
assessment of certain critical care tests and rapid point-of-care tests for
Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through
its AVRL division, provides routine laboratory testing as well as specialty
testing for veterinarians nationwide.  For more information, visit
http://www.abaxis.com.

Contact: Clint Severson          Lytham Partners, LLC
         Chief Executive Officer Joe Dorame, Joe Diaz & Robert Blum
         ABAXIS, Inc.            602-889-9700
         510-675-6500

SOURCE Abaxis, Inc.

Website: http://www.abaxis.com
Sponsored Links
Advertisement
Advertisements
Sponsored Links
Advertisement